Ypsomed Holding Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St

May 27, 2024

Ypsomed Holding (VTX:YPSN) Full Year 2024 Results

Key Financial Results

Revenue: CHF548.5m (up 10% from FY 2023).
Net income: CHF78.4m (up 53% from FY 2023).
Profit margin: 14% (up from 10% in FY 2023). The increase in margin was driven by higher revenue.
EPS: CHF5.74 (up from CHF3.82 in FY 2023).

revenue-and-expenses-breakdown — SWX:YPSN Revenue and Expenses Breakdown May 27th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ypsomed Holding EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 3.2%.

The primary driver behind last 12 months revenue was the Ypsomed Delivery Systems segment contributing a total revenue of CHF385.2m (70% of total revenue). Notably, cost of sales worth CHF359.4m amounted to 66% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to CHF78.9m (71% of total expenses). Explore how YPSN's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Medical Equipment industry in Switzerland.

Performance of the Swiss Medical Equipment industry.

The company's shares are up 18% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 1 warning sign for Ypsomed Holding that you need to be mindful of.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.